LinkedIn Facebook Instagram YouTube ADVERTISE WITH US

Click here to subscribe to our newsletter

  Industry Insights  
 

Menopause Hormonal Pathways Driving New Therapeutic Options

Menopause hormonal pathways research is driving new therapeutic options, from refined hormone therapies to non-hormonal drugs, for developers and investors.

READ MORE
 

 
 
 
   

Female Clinical Endpoints Improving Therapeutic Development

Discover how female clinical endpoints improve therapeutic development, closing sex-based data gaps in trials to deliver safer, more effective women's drugs.

READ MORE
 
 
 
 

Sex-Specific Clinical Evidence Incorporating Female Trials

Explore how enrolling women in trials, choosing sex-aware endpoints and using real-world data enable sex-specific clinical evidence and safety signals.

READ MORE
 

 
 
 
   

Female-Specific Biomarkers Changing Autoimmune Drug Development

Female-specific biomarkers are reshaping cardiovascular and autoimmune drug development, aiding patient selection, target validation and late-stage success.

READ MORE
 
 
 
 

Female Cohort Representation Strengthening Clinical Evidence

Female cohort representation strengthens clinical trial evidence, safety signals and regulatory confidence. Learn how sponsors can close the gender data gap.

READ MORE
 

 
 
 
   

Female Cardiovascular Biomarkers Advancing Drug Development

Female cardiovascular biomarkers help drug developers optimize clinical trial stratification, validate target response, and reduce costly pipeline attrition.

READ MORE
 
 
 
  Advertising:

Peter Menon
marketing@pharmaadvancement.com
Phone: +91 6304637675
  For the latest visit: http://www.pharmaadvancement.com/